arGEN X (0QW0) Receives a Buy from Barclays
Stay Ahead of the Market:
Discover outperforming stocks and invest smarter with Top Smart Score Stocks.
Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener.
According to TipRanks, Pitman CFA is a 4-star analyst with an average return of 9.3% and a 52.81% success rate.
Currently, the analyst consensus on arGEN X is a Strong Buy with an average price target of €681.13, which is a 93.39% upside from current levels. In a report released on April 20, Bank of America Securities also maintained a Buy rating on the stock with a €680.00 price target.
The company has a one-year high of €656.80 and a one-year low of €324.30. Currently, arGEN X has an average volume of 13.3K.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
an hour ago
- Business Insider
Barclays Sticks to Its Buy Rating for Galderma Group AG (GALD)
Barclays analyst Yihan Li maintained a Buy rating on Galderma Group AG on July 25 and set a price target of CHF140.00. The company's shares closed last Friday at CHF134.50. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Li is ranked #6568 out of 9862 analysts. Galderma Group AG has an analyst consensus of Strong Buy, with a price target consensus of CHF130.52, which is a -2.96% downside from current levels. In a report released on July 25, Citi also maintained a Buy rating on the stock with a CHF140.00 price target. Based on Galderma Group AG's latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of CHF1.93 billion and a net profit of CHF160.43 million. In comparison, last year the company earned a revenue of CHF1.84 billion and had a GAAP net loss of CHF54.18 million
Business Insider
an hour ago
- Business Insider
Barclays Remains a Buy on Cadence Bank (CADE)
In a report released on July 25, Jared Shaw from Barclays maintained a Buy rating on Cadence Bank, with a price target of $43.00. The company's shares closed last Friday at $36.42. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Shaw is a 3-star analyst with an average return of 1.1% and a 53.28% success rate. Shaw covers the Financial sector, focusing on stocks such as UMB Financial, Cadence Bank, and BankUnited. In addition to Barclays, Cadence Bank also received a Buy from Morgan Stanley's Manan Gosalia in a report issued on July 25. However, on July 24, RBC Capital maintained a Hold rating on Cadence Bank (NYSE: CADE). Based on Cadence Bank's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $683.78 million and a net profit of $133.22 million. In comparison, last year the company earned a revenue of $720.9 million and had a net profit of $116.98 million
Business Insider
an hour ago
- Business Insider
Barclays Keeps Their Hold Rating on Treatt plc (TET)
In a report released on July 25, Setu Sharda from Barclays maintained a Hold rating on Treatt plc, with a price target of £2.20. The company's shares closed last Friday at p206.00. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Sharda is an analyst with an average return of -13.3% and a 26.67% success rate. Sharda covers the Basic Materials sector, focusing on stocks such as AAK AB, Treatt plc, and Corbion NV. In addition to Barclays, Treatt plc also received a Hold from TR | OpenAI – 4o's Dorian Reaxon in a report issued on July 26. However, on July 25, Berenberg Bank maintained a Buy rating on Treatt plc (LSE: TET). TET market cap is currently £121.4M and has a P/E ratio of 11.17.
